Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications
about
Loss of p27 upregulates MnSOD in a STAT3-dependent manner, disrupts intracellular redox activity and enhances cell migration.Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics.Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear-cell renal cell carcinoma.MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinomaGenome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome.Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.Non-invasive differentiation of benign renal tumors from clear cell renal cell carcinomas using clinically translatable hyperpolarized (13)C pyruvate magnetic resonance.Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell CarcinomaRole of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response.Hypoxia and fatty liver.Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer.Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell CarcinomaA computational method using differential gene expression to predict altered metabolism of multicellular organisms.Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.Renal cell carcinoma: a review of biology and pathophysiology.Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer.
P2860
Q33822389-FEC82EE1-9078-4FB8-A18B-56DEA5E02B8AQ33824587-F157C15F-EAB3-4B89-80DE-C90C924B77EDQ33869708-5893744C-87D8-49AC-86EE-6A4773D1C2E2Q34489747-43FD8DC2-0070-43B2-80A7-0744C80BB670Q35090735-7B075800-ED47-4A2D-8CC9-6FB81FE432D2Q35567752-0F96F10F-4F9B-4389-A663-C8037732DF04Q36045221-EA71CA89-4B9C-40A9-BE70-DA9AC8E7E629Q36818377-68865C0E-B581-40FD-91EC-355906944051Q36926275-69BD50BF-E71B-4DEA-BCDA-42E5F6102DEAQ36963431-EB1FECC0-DF7A-4923-B267-39F4AD4FBA61Q37050481-31C77934-6F39-4AFC-8B17-DABD74D56C82Q37180374-39CC2EC8-A7FD-402A-A38D-9F04403CE216Q38266865-515C4EC3-B814-4EE7-831E-A879BE204DD6Q41835918-9664F7C2-D5A5-4278-AC51-813A75561E44Q42293369-C3ABC180-07F9-45D6-9807-4BAA26E7E288Q47876075-7F63F51A-C056-43A1-9C10-DAEBFAF30ABEQ51204575-D9AC1225-A17B-4AF8-B1A7-5431FCECE85FQ51767200-F60A3BA2-1807-41EA-B368-7BC52F7B9DC5Q51817159-3879CD65-FCF6-4E2B-AC06-1E32438504BDQ52724797-DE11258F-D13C-4DF2-86D9-9F8F6A5A8845Q55419613-67489591-B7B4-4E41-80ED-A0D1AC228087
P2860
Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabolic features of clear-ce ...... isms and clinical implications
@ast
Metabolic features of clear-ce ...... isms and clinical implications
@en
type
label
Metabolic features of clear-ce ...... isms and clinical implications
@ast
Metabolic features of clear-ce ...... isms and clinical implications
@en
prefLabel
Metabolic features of clear-ce ...... isms and clinical implications
@ast
Metabolic features of clear-ce ...... isms and clinical implications
@en
P2093
P2860
P356
P1476
Metabolic features of clear-ce ...... isms and clinical implications
@en
P2093
Daniel Gallino
Jehonathan H Pinthus
Jian-Ping Lu
Kaitlyn F Whelan
Nathan Rothschild
P2860
P304
P356
10.5489/CUAJ.10196
P577
2011-08-01T00:00:00Z